期刊文献+

盐酸帕洛诺司琼预防化疗所致恶心呕吐的临床观察 被引量:13

Clinical trial of treating nausea and vomiting caused by chemotherapy with palonosetron
原文传递
导出
摘要 为了探讨盐酸帕洛诺司琼预防中重度化疗所致恶心和呕吐的疗效和安全性,采用随机对照的研究方法,研究组(32例)用药为盐酸帕洛诺司琼注射液,对照组(33例)用药为阿扎司琼注射液。对化疗后恶心止吐疗效进行评价。研究组和对照组对急性呕吐的控制率分别为78.1%(25/32)和78.8%(26/33),2组差异无统计学意义,P>0.05;而对于迟发性呕吐,帕洛诺司琼注射液优于阿扎司琼,P<0.05。盐酸帕洛诺司琼注射液的毒副反应主要为便秘。初步研究结果提示,盐酸帕洛诺司琼注射液能够预防化疗引起的急性和迟发性恶心、呕吐,疗效和安全性较好。 The objective of this study was to investigate the efficacy and safety of palonosetron hydrochloride in prevention of nausea and vomit induced by chemotherapy.All cases were randomly divided into two groups,32 cases in a study group(treated with palonosetron) and 33 cases in a control group(treated with azasetron).Response rates of prevention of acute vomit were 78.1%(25/32) and 78.8%(26/33) in two groups(P0.05),while palonosetron was superior to azasetron in the prevention of chronic vomit(P0.05).Only a few patients in two groups appeared slight constipation.In conclusion,palonosetron hydrochloride is effective and safe for prevention of nausea and vomit induced by chemotherapy.
出处 《中华肿瘤防治杂志》 CAS 2010年第23期1976-1977,共2页 Chinese Journal of Cancer Prevention and Treatment
关键词 肿瘤 药物疗法 化学预防 恶心 呕吐 neoplasms drug therapy chemoprevention nausea vomiting
  • 相关文献

参考文献6

  • 1Eisenberg P, Mackintosh F R, Ritch P, et al. Efficacy, safety and pharmacokinotics of palonosetron in patients receiving highly emetogenic cisplatin-based chemotherapy: a dose-ranging clinical study[J]. Ann Oneol, 2004, 15(2) :330 -337.
  • 2Eisenberg P, Figueroa Vadillo J, Zamora R, et al. Improved prevention of moderately emetogenic chemotherapy induced nausea and vomiting with palonosetron, a pharmacologically novel 5- HT3 receptor antagonist:results of a phase Ⅲ, single-dose trial versus dolasetron[J]. Cancer, 2003, 98 (11) : 2473-2482.
  • 3张恩宁,曲维庆,刘磊,王萍,仲昭坤,付爱芹,刘曙亮,路志丽,于泽.甲地孕酮联合昂丹司琼对胃肠道肿瘤化疗所致呕吐预防效果的临床观察[J].中华肿瘤防治杂志,2009,16(17):1329-1331. 被引量:8
  • 4Gralla R, Lichinitser M, van Dervegt S, et al. Palonosetron im- proves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blindrandomized phase Ⅲ trial comparing single doses of palonosetron with ondansetron[J]. Ann Oneol, 2003,14 (10) : 1570-1577.
  • 5Aapro M S, Grunberg S M, Manikhas G M, et al. A phase Ⅲ , double blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy [J]. Ann Oncol, 2006,17(9) :1441-1449.
  • 6Grunberg S M, Koeller J M. Palonosetron: a unique 5 HT3 receptor antagonist for the prevention of chemotherapy-induced emesis[J]. Expert Opin Pharmacother,2003,4(12) :2297-2303.

二级参考文献10

  • 1张晓静,张频.肿瘤化疗所致恶心呕吐的发生机制和药物治疗的研究进展[J].癌症进展,2006,4(4):348-354. 被引量:126
  • 2Wiser W, Berger A. Practical management of chemotherapy-duced nausea and vomiting[J]. Oncology (Williston Park), 2005, 19(5):637-645.
  • 3Fiorica J V, Brunetto V L, Hanjani P, et al. Phase Ⅱ trial of al ternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gymecologic Oncology Group study [J]. Gynecol Oncol, 2004,92 (1) : 10-14.
  • 4Ruiz Oarcia V,Juan O,Perez Hoyos S,et al. Megestrol acetate:a systematic review usefulness about the weight gain in neoplastic Clin ( Barc), 2002,119 ( 5 ) : 166.
  • 5Cubeddu L X. Serotonin mechanisms in chemotherapy induced emesis in cancer patients[J]. Oncology, 1996, 53(Suppl 1) : 18-25.
  • 6Roila F, Donati D, Tamberi S, et al. Delayed emesis:Incidence, pattern, prognostic factors and optimal treatment[J]. Support Care Cancer, 2002,10(2): 88-95.
  • 7张天泽 徐光炜.肿瘤学[M].天津:天津科学技术出版社,1996.1209.
  • 8曲维庆,张恩宁,付爱芹,刘磊,王萍.甲地孕酮联合昂丹司琼治疗肿瘤化疗中呕吐[J].肿瘤学杂志,2008,14(10):849-851. 被引量:2
  • 9林千鹤子,韩少良.抗癌药物毒副反应的对策[J].日本医学介绍,2001,22(11):491-493. 被引量:59
  • 10段玉龙,侯俊卿,范向辉.甲地孕酮在恶性肿瘤化疗中的应用[J].肿瘤防治杂志,2003,10(2):204-205. 被引量:5

共引文献7

同被引文献115

引证文献13

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部